SCHEDULE 13G/A: Royce & Associates LP Discloses 5.29% Passive Stake in Mesa Laboratories, Inc.

Royce & Associates LP has filed an amended Schedule 13G, reporting a passive beneficial ownership of 5.29% of Mesa Laboratories, Inc.'s common stock as of December 31, 2024.

Summary

• Royce & Associates LP reported beneficial ownership of 287,207 shares of Mesa Laboratories, Inc. common stock.
• This represents 5.29% of the total outstanding shares of the class of securities.
• The filing is an Amendment No. 12 to a previous Schedule 13G, with the event date requiring the filing being December 31, 2024.
• Royce & Associates LP holds sole voting power and sole dispositive power over all 287,207 reported shares.
• The firm is classified as an Investment Adviser (IA) and certifies that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of the issuer.
• Royce & Associates LP, an indirect majority-owned subsidiary of Franklin Resources, Inc., clarifies that it exercises investment and voting powers independently from Franklin Resources, Inc. and its other affiliates, and disclaims being part of a 'group' for regulatory purposes.

Sentiment

Score: 6

Explanation: The filing is a routine disclosure of passive institutional ownership, indicating continued investment by Royce & Associates LP in Mesa Laboratories, Inc. without suggesting any significant new developments or changes in company fundamentals. It's a neutral to slightly positive signal due to the continued institutional interest.

Positives

• A significant institutional investor, Royce & Associates LP, maintains a 5.29% stake in Mesa Laboratories, Inc., indicating continued investment interest and confidence in the company.

Risks

• Royce & Associates LP explicitly disclaims being a 'group' with Franklin Resources, Inc. affiliates or Principal Shareholders, which could otherwise imply coordinated control or influence over Mesa Laboratories, Inc.

Future Outlook

NA

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect."
• "RALP disclaims any pecuniary interest in any of the securities reported in this Schedule 13G."
• "RALP believes that it is not a 'group' with FRI affiliates, the Principal Shareholders, or their respective affiliates within the meaning of Rule 13d-5 under the Act and that none of them is otherwise required to attribute to any other the beneficial ownership of the securities held by such person or by any persons or entities for whom or for which RALP or the FRI affiliates provide investment management services."

Industry Context

NA

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake, potentially offering a degree of confidence in the company's long-term prospects due to continued institutional investment.

Key Dates

Recommendation

Keywords

Mesa Laboratories Inc., ROYCE & ASSOCIATES LP, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Investment Adviser, Passive Investment, Franklin Resources Inc.